Evidence map›Paper›PMID 36139076›Full record

ArticleBiomolecules2022

A New Product of Bilirubin Degradation by H

Fei-Fei Yu, Yao Yuan, Yan Ao, Li Hua, Wu Wang, Yiyi Cao, Jing Xi, Yang Luan, Shangwei Hou, Xin-Yu Zhang

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Fei-Fei YuInstitute of Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.
Yao YuanShanghai Jiao Tong University-Hangzhou Future Sci-Tech City Joint Research Center for Tumor Immunotherapy, Hangzhou Innovation Institute for Systems Oncology, Hangzhou 311121, China.
Yan AoMinistry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Li HuaSchool of Public Health, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-6816-0786
Wu WangInstitute of Environmental Pollution and Health, School of Environmental and Chemical Engineering, Shanghai University, Shanghai 200444, China.
Yiyi CaoSchool of Public Health, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Jing XiSchool of Public Health, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Yang LuanSchool of Public Health, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0002-2211-7803
Shangwei HouShanghai Jiao Tong University-Hangzhou Future Sci-Tech City Joint Research Center for Tumor Immunotherapy, Hangzhou Innovation Institute for Systems Oncology, Hangzhou 311121, China.
Xin-Yu ZhangSchool of Public Health, Hongqiao International Institute of Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.ORCID 0000-0003-3472-8393
Shanghai Jiao Tong University · CNShanghai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bilirubin (BR) is a tetrapyrrolic compound stemming from heme catabolism with diverse physiological functions. It can be oxidized by H

Indexed as

NeutrophilsPropionatesAcetatesAnimalsBilirubinChromatography, LiquidHemeHydrogen PeroxideInflammationMiceMyristatesReactive Oxygen SpeciesTandem Mass SpectrometryTetradecanoylphorbol AcetateAcetatesBilirubinHemeHydrogen PeroxideMyristatesPropionatesReactive Oxygen SpeciesTetradecanoylphorbol Acetatebilirubindegradationhemorrhagehydrogen peroxideinflammationneutrophil

Identifiers

PMID36139076
PMCPMC9496627
OpenAlexW4294989664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.